Literature DB >> 28527775

Antithrombotic Therapy for Prevention of Cerebral Thromboembolic Events After Transcatheter Aortic Valve Replacement: Evolving Paradigms and Ongoing Directions.

Davide Capodanno1, Dominick J Angiolillo2.   

Abstract

Entities:  

Keywords:  TAVR; anticoagulant therapy; antiplatelet therapy; antithrombotic therapy

Mesh：

Substances：

Year:  2017        PMID： 28527775     DOI： 10.1016/j.jcin.2017.05.005

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.195


× No keyword cloud information.
  4 in total

1.  Antithrombotic therapy after transcatheter aortic valve implantation: a new piece of the still unresolved puzzle.

Authors:  Giuseppe Gargiulo; Marco Valgimigli
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 2.  Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease.

Authors:  Davide Capodanno; Deepak L Bhatt; John W Eikelboom; Keith A A Fox; Tobias Geisler; C Michael Gibson; Jose Ramon Gonzalez-Juanatey; Stefan James; Renato D Lopes; Roxana Mehran; Gilles Montalescot; Manesh Patel; P Gabriel Steg; Robert F Storey; Pascal Vranckx; Jeffrey I Weitz; Robert Welsh; Uwe Zeymer; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2020-01-17       Impact factor: 32.419

Review 3.  Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status.

Authors:  Antonio Greco; Davide Capodanno
Journal:  Interv Cardiol       Date:  2020-04-23

4.  Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement.

Authors:  Hanbit Park; Do-Yoon Kang; Jung-Min Ahn; Kyung Won Kim; Anthony Y T Wong; Simon C C Lam; Wei-Hsian Yin; Jeng Wei; Yung-Tsai Lee; Hsien-Li Kao; Mao-Shin Lin; Tsung-Yu Ko; Won-Jang Kim; Se Hun Kang; Euihong Ko; Dae-Hee Kim; Hyun Jung Koo; Dong Hyun Yang; Joon-Won Kang; Seung Chai Jung; Jae-Hong Lee; Sung-Cheol Yun; Seung-Jung Park; Duk-Woo Park
Journal:  BMJ Open       Date:  2021-01-05       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.